Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
07/06/2011 | CN102114092A Baicao oil for external use |
07/06/2011 | CN102114082A Compound giant knotweed emulsion for preventing livestock and poultry infection |
07/06/2011 | CN102114064A Externally used medicine for treating thrush and preparation method thereof |
07/06/2011 | CN102114044A Artificially processed bear bile powder and preparation method thereof |
07/06/2011 | CN102114041A Composition for treating fowl cholera and preparation method thereof |
07/06/2011 | CN102114027A Oxygen-driven atomized inhalation solution for infant asthmatic suffocating pneumonia |
07/06/2011 | CN102114026A Ointment preparation for treating duck leg diseases and preparation method thereof |
07/06/2011 | CN102114020A Pharmaceutical composition containing besivance or salts thereof and preparation method thereof |
07/06/2011 | CN102114019A Compound cefaclor preparation and preparation method |
07/06/2011 | CN102114010A Medicinal composition for treating gastrointestinal disorders as well as preparation method and application thereof |
07/06/2011 | CN102113973A Oral cavity disinfecting liquor and production method thereof |
07/06/2011 | CN102113524A Chinese medicinal disinfectant |
07/06/2011 | CN101955915B Method for producing influenza virus vaccine |
07/06/2011 | CN101773569B Oral Chinese medicine liquid for treating chicken infectious laryngotracheitis |
07/06/2011 | CN101773469B Aztreonam/arginine medicament composition suspension injection |
07/06/2011 | CN101721371B Cefetamet pivoxil hydrochloride submicron emulsion solid preparation and new application thereof |
07/06/2011 | CN101708166B Cefpodoxime proxetil submicron emulsion solid preparation and novel application thereof |
07/06/2011 | CN101703549B Atractylone lipidosome and preparation method thereof |
07/06/2011 | CN101693010B Cefathiamidine prosoma liposome preparation |
07/06/2011 | CN101671348B Ceftizoxime sosium compound of new way |
07/06/2011 | CN101653518B Medicinal composition for treating child diarrhea and child infectious diarrhea and preparation method |
07/06/2011 | CN101648991B Small peptide C with antibacterial and antitumor functions and applications thereof |
07/06/2011 | CN101648962B C3/C3 fluoroquinolone dipolymer derivative taking s-triazolo-[3,4-b][1,3,4] thiadiazole as connecting chain and preparation method and application thereof |
07/06/2011 | CN101647936B Manufacture method of mouth care lozenges |
07/06/2011 | CN101612204B Medicament-resistant inhibitor for porcine streptococcus |
07/06/2011 | CN101612175B Separation and identification of syringa amurensis rupr. bark volatile oil components and novel application |
07/06/2011 | CN101585843B Process for preparing rifaximin |
07/06/2011 | CN101579420B External medicine for curing lepriasis old ulcerative-point erosion as well as burns and scalds |
07/06/2011 | CN101560236B Method for synthesizing marine polyhydroxyl sterol (25R)-5alpha -cholest-3 beta, 5alpha, 6beta, 26-tetrol |
07/06/2011 | CN101538327B Anthropogenic H5N1-resisting hemagglutinin protein broad-spectrum neutralising antibody and application thereof |
07/06/2011 | CN101444514B Cefmenoxime hydrochloride preparation for injection and preparation method thereof |
07/06/2011 | CN101381365B Dual action antibiotics |
07/06/2011 | CN101304741B Water-soluble antiviral agent based on silver-cistine compound and method of preparing thereof |
07/06/2011 | CN101280326B Preparation and application of compound for inhabiting aspergillus fumigatus activity |
07/06/2011 | CN101239091B Composition for preventing and controlling helicobacter pylori affection |
07/06/2011 | CN101119986B Optically active tetrahydronaphthalene derivative |
07/06/2011 | CN101014572B Carbamoylpyridone derivative having HIV integrase inhibitory activity |
07/06/2011 | CN101007062B Traditional Chinese medicine composition capable of resisting infection |
07/05/2011 | US7973153 Antigen, nucleic acid encodes fusion protein; polynucleotides; nucleoside sequences |
07/05/2011 | US7973151 Nucleic acid encoding modified human thymic stromal lymphopoietin |
07/05/2011 | US7973080 Method for inhibiting the growth of antibiotic resistant of bacteria by using pentane-1,5-diol |
07/05/2011 | US7973044 Heteroaryl, heterocyclic and aryl compounds which inhibit leukocyte adhesion mediated by VLA-4 |
07/05/2011 | US7973040 Macrocyclic quinoxaline compounds as HCV NS3 protease inhibitors |
07/05/2011 | US7972845 Human antibodies against Pseudomonas aeruginosa LPS derived from transgenic xenomouse |
07/05/2011 | US7972843 DNA-transfection system for the generation of infectious influenza virus |
07/05/2011 | US7972814 Antimicrobial polypeptides from Pseudoplectania nigrella |
07/05/2011 | US7972777 Nucleic acid probe-based diagnostic assays targeting ssrA genes of prokaryotic and eukaryotic organisms |
07/05/2011 | US7972629 Product comprising a combination of milk serum apoproteins and free fatty acids |
07/05/2011 | CA2660818C Antibacterial agent and therapeutic agent for johne's disease containing the same |
07/05/2011 | CA2577247C Method for manufacturing enantiomeric imidazole compounds |
07/05/2011 | CA2533434C Artificial cpg single-stranded oligodeoxynucleotide and antiviral use thereof |
07/05/2011 | CA2504872C Use of resveratrol for the preparation of a medicament useful for the treatment of influenza virus infections |
07/05/2011 | CA2476583C Aminocarbonyl-derivatives as novel inhibitors of histone deacetylase |
07/05/2011 | CA2475867C Oxa- and thiadiazoles and their use as metalloproteinase inhibitors |
07/05/2011 | CA2459172C Bicyclic compound, production and use thereof |
07/05/2011 | CA2451866C Nutritional composition preventing bacterial overgrowth |
07/05/2011 | CA2446971C Use of 3-position cyclosporin derivatives for hair growth |
07/05/2011 | CA2427475C Purification of hbv antigens for use in vaccines |
07/05/2011 | CA2423279C Phthalazinone derivatives |
07/05/2011 | CA2220133C Recombinant vesiculoviruses and their uses |
07/05/2011 | CA2217745C Oxygenated-heterocycle containing sulfonamide inhibitors of aspartyl protease |
06/30/2011 | WO2011079327A1 Analogues for the treatment or prevention of flavivirus infections |
06/30/2011 | WO2011079260A2 Stabilized virus like particles having enhanced mucosal immunogenicity |
06/30/2011 | WO2011079249A2 Use of vitamin d glycosides and sulfates for treatment of disease |
06/30/2011 | WO2011079234A2 Highly permeating terbinafine formulation |
06/30/2011 | WO2011079034A1 Extracts from kibdelos porangium as antibacterial agents |
06/30/2011 | WO2011079016A1 Methods of treating hbv and hcv infection |
06/30/2011 | WO2011078820A1 Pharmaceutical formulations comprising a third generation cephalosporin and clavulanic acid |
06/30/2011 | WO2011078221A1 Imidazopyridazine compounds |
06/30/2011 | WO2011077171A1 4-phenylamino-pyrimidine derivatives having protein kinase inhibitor activity |
06/30/2011 | WO2011077100A1 Antiretroviral composition |
06/30/2011 | WO2011076923A1 Inhibitor for inosine monophosphate (imp) dehydrogenase and/or viral rna polymerase for treatment of hepatitis e |
06/30/2011 | WO2011076873A1 Influenza targets |
06/30/2011 | WO2011076811A1 Carboxamide compounds and their use as calpain inhibitors |
06/30/2011 | WO2011076765A1 Novel antiviral compounds |
06/30/2011 | WO2011076327A1 Pyrrolo[2,3-d]pyrazin-7-yl pyrimidine compounds |
06/30/2011 | WO2011076086A1 Intermediate compounds of tamiflu, methods of preparation and uses thereof |
06/30/2011 | WO2011076048A1 Medical and pharmaceutical use of 2', 2-bis-thiazole non-nucleoside compounds as hepatitis c virus inhibitor |
06/30/2011 | WO2011075823A1 Immunogenic compositions |
06/30/2011 | WO2011075822A1 Immunogenic compositions and related methods |
06/30/2011 | WO2011075766A1 Antimicrobial compounds |
06/30/2011 | WO2011060613A9 Human alpha-defensin 5 mutant polypeptide and preparation method and use thereof |
06/30/2011 | WO2011056741A3 Coated drug spheroids and uses thereof for eliminating or reducing conditions such as emesis and diarrhea |
06/30/2011 | WO2011038933A3 Anti-hsv antibody |
06/30/2011 | WO2011014008A3 Novel 3-phenoxy-4-pyrone, 3-phenoxy-4-pyridone, or 4-pyridone derivatives, method for preparing same, and antimicrobial composition containing same as an active ingredient |
06/30/2011 | WO2011013992A3 R-7-(3-aminomethyl-4-methoxyimino-3-methyl-pyrrolidin-1-yl)-1-cyclopropyl-6-fluoro-4-oxo-1,4-dihydro-[1,8]naphthyridine-3-carboxylic acid and l-aspartic acid salt, process for the preparation thereof and pharmaceutical composition comprising the same for antimicrobial |
06/30/2011 | WO2011012855A3 Antibacterial combinations comprising a garlic extract or s -allyl cysteine |
06/30/2011 | WO2010150982A3 Recombinant hemagglutinin protein having superior biocompatibility for an influenza virus vaccine, and method for preparing biodegradable plga microspheres containing same |
06/30/2011 | WO2010117287A3 A virus-like particle vector for delivery of pharmaceutical agents, a process for the manufacture thereof, its uses and a pharmaceutical composition. |
06/30/2011 | US20110162115 Recombinant ndv antigen and uses thereof |
06/30/2011 | US20110162095 TNFSF Single Chain Molecules |
06/30/2011 | US20110160845 Drug delivery system and method of manufacturing thereof |
06/30/2011 | US20110160309 Interleukin-1 and tumor necrosis factor-alpha modulators; syntheses of such modulators and methods of using such modulators |
06/30/2011 | US20110160305 Oral Delivery of Therapeutic Doses of Glutathione |
06/30/2011 | US20110160304 Inhibitors of Yeast Filamentous Growth and Method of Their Manufacture |
06/30/2011 | US20110160289 Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis |
06/30/2011 | US20110160252 Pharmaceutical compositions for treatment or prevention of hbv infection |
06/30/2011 | US20110160243 Substituted tricyclic acid derivatives as s1p1 receptor agonists useful in the treatment of autoimmune and inflammatory disorders |
06/30/2011 | US20110160235 Triazolyl tropane derivatives |
06/30/2011 | US20110160233 Anti-viral compounds |